NCT06632912 2026-01-23Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule BridgingNational Vaccine and Serum Institute, ChinaPhase 3 Active not recruiting1,800 enrolled
NCT05831111 2025-09-30A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsModernaTX, Inc.Phase 1 Active not recruiting482 enrolled
NCT06790420 2025-05-31RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database StudyPfizerCompleted1 enrolled
NCT03098589 2025-03-30Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CelgeneCompleted1,149 enrolled